Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Squamous Cell Transformation of Primary Lung Adenocarcinoma in a Patient With EML4-ALK Fusion Variant 5 Refractory to ALK Inhibitors.

Gong J, Gregg JP, Ma W, Yoneda K, Moore EH, Daly ME, Zhang Y, Williams MJ, Li T.

J Natl Compr Canc Netw. 2019 Apr 1;17(4):297-301. doi: 10.6004/jnccn.2019.7291.

PMID:
30959466
2.

Ensartinib (X-396): what does it add for patients with ALK-rearranged NSCLC.

Li T, Ma W, Tian EC.

Chin Clin Oncol. 2018 Nov 9. pii: cco.2018.10.12. doi: 10.21037/cco.2018.10.12. [Epub ahead of print] No abstract available.

3.

Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer.

Li Q, Ma W, Li T.

J Thorac Dis. 2018 Sep;10(Suppl 26):S3186-S3191. doi: 10.21037/jtd.2018.08.25. No abstract available.

4.

Clinical utility of tumor genomic profiling in patients with high plasma circulating tumor DNA burden or metabolically active tumors.

Zhou C, Yuan Z, Ma W, Qi L, Mahavongtrakul A, Li Y, Li H, Gong J, Fan RR, Li J, Molmen M, Clark TA, Pavlick D, Frampton GM, Forcier B, Moore EH, Shelton DK, Cooke M, Ali SM, Miller VA, Gregg JP, Stephens PJ, Li T.

J Hematol Oncol. 2018 Nov 6;11(1):129. doi: 10.1186/s13045-018-0671-8.

5.

Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.

Wang Y, Jing W, Ma W, Liang C, Chai H, Tu J.

Cancer Biomark. 2018;22(2):227-236. doi: 10.3233/CBM-170781.

PMID:
29660898
6.

The Abnormal Expression of MicroRNA-542-3p in Hepatocellular Carcinoma and Its Clinical Significance.

Chen X, Zhang Q, Ma W, Lan T, Hong Z, Yuan Y.

Dis Markers. 2018 Feb 11;2018:3973250. doi: 10.1155/2018/3973250. eCollection 2018.

7.

The prognostic value of long noncoding RNAs in prostate cancer: a systematic review and meta-analysis.

Ma W, Chen X, Ding L, Ma J, Jing W, Lan T, Sattar H, Wei Y, Zhou F, Yuan Y.

Oncotarget. 2017 May 7;8(34):57755-57765. doi: 10.18632/oncotarget.17645. eCollection 2017 Aug 22. Review.

8.

Long non-coding RNA PVT1 serves as a competing endogenous RNA for miR-186-5p to promote the tumorigenesis and metastasis of hepatocellular carcinoma.

Lan T, Yan X, Li Z, Xu X, Mao Q, Ma W, Hong Z, Chen X, Yuan Y.

Tumour Biol. 2017 Jun;39(6):1010428317705338. doi: 10.1177/1010428317705338.

PMID:
28656879
9.

T-cell-associated immunotherapy: a promising strategy for the treatment of hepatocellular carcinoma.

Ma W, Chen X, Yuan Y.

Immunotherapy. 2017 Jun;9(7):523-525. doi: 10.2217/imt-2017-0053. No abstract available.

10.

Clinical significance of C/D box small nucleolar RNA U76 as an oncogene and a prognostic biomarker in hepatocellular carcinoma.

Wu L, Chang L, Wang H, Ma W, Peng Q, Yuan Y.

Clin Res Hepatol Gastroenterol. 2018 Feb;42(1):82-91. doi: 10.1016/j.clinre.2017.04.018. Epub 2017 May 31.

PMID:
28578939
11.

Severe nivolumab-induced pneumonitis preceding durable clinical remission in a patient with refractory, metastatic lung squamous cell cancer: a case report.

Li H, Ma W, Yoneda KY, Moore EH, Zhang Y, Pu LL, Frampton GM, Molmen M, Stephens PJ, Li T.

J Hematol Oncol. 2017 Feb 28;10(1):64. doi: 10.1186/s13045-017-0433-z.

12.

T Cell-Associated Immunotherapy for Hepatocellular Carcinoma.

Ma W, Wu L, Zhou F, Hong Z, Yuan Y, Liu Z.

Cell Physiol Biochem. 2017;41(2):609-622. doi: 10.1159/000457883. Epub 2017 Feb 3. Review.

13.

Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes tumorigenesis and metastasis by targeting miR-199a/b-5p in hepatocellular carcinoma.

Lan T, Ma W, Hong Z, Wu L, Chen X, Yuan Y.

J Exp Clin Cancer Res. 2017 Jan 10;36(1):11. doi: 10.1186/s13046-016-0486-9.

14.

Human Endogenous Retroviruses-K (HML-2) Expression Is Correlated with Prognosis and Progress of Hepatocellular Carcinoma.

Ma W, Hong Z, Liu H, Chen X, Ding L, Liu Z, Zhou F, Yuan Y.

Biomed Res Int. 2016;2016:8201642. doi: 10.1155/2016/8201642. Epub 2016 Dec 14.

15.

Feasibility and Efficacy of S-Adenosyl-L-methionine in Patients with HBV-Related HCC with Different BCLC Stages.

Guo T, He Y, Ma W, Liu Z, Liu Q.

Gastroenterol Res Pract. 2016;2016:4134053. doi: 10.1155/2016/4134053. Epub 2016 Nov 28.

16.

Downregulation of long non-coding RNAs JPX and XIST is associated with the prognosis of hepatocellular carcinoma.

Ma W, Wang H, Jing W, Zhou F, Chang L, Hong Z, Liu H, Liu Z, Yuan Y.

Clin Res Hepatol Gastroenterol. 2017 Mar;41(2):163-170. doi: 10.1016/j.clinre.2016.09.002. Epub 2016 Oct 22.

PMID:
27776968
17.

Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy.

Ma W, Gilligan BM, Yuan J, Li T.

J Hematol Oncol. 2016 May 27;9(1):47. doi: 10.1186/s13045-016-0277-y. Review.

18.

The human RNA surveillance factor UPF1 regulates tumorigenesis by targeting Smad7 in hepatocellular carcinoma.

Chang L, Li C, Guo T, Wang H, Ma W, Yuan Y, Liu Q, Ye Q, Liu Z.

J Exp Clin Cancer Res. 2016 Jan 13;35:8. doi: 10.1186/s13046-016-0286-2.

Supplemental Content

Loading ...
Support Center